Literature DB >> 2682959

The molecular biology of Borrelia.

A G Barbour1.   

Abstract

Borrelia burgdorferi, the cause of Lyme disease, has two major outer-membrane proteins, OspA and OspB, which act as surface antigens. A 49-kilobase linear plasmid contains the genes that encode for these surface proteins. Direct examination of denatured plasmid molecules has revealed single-stranded circles with a circumference of approximately 100 kilobases (about twice the length of the linear duplex molecule), a finding that indicates the plasmid strands have covalently closed ends. This form of DNA, while present in eukaryotic organisms and their viruses, has not been observed in a prokaryotic organism. Plasmid heterogeneity has been observed in strains with surface proteins of similar molecular weights and similar monoclonal antibody reactivity. Thus, plasmid analysis may prove a sensitive tool for differentiating strains of B. burgdorferi. Furthermore, since loss of plasmids in vitro has been correlated with loss of the ability of many-passaged strains to cause infection, borrelial plasmids may encode for virulence factors as well.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2682959     DOI: 10.1093/clinids/11.supplement_6.s1470

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  10 in total

1.  CsrA modulates levels of lipoproteins and key regulators of gene expression critical for pathogenic mechanisms of Borrelia burgdorferi.

Authors:  S L Rajasekhar Karna; Eva Sanjuan; Maria D Esteve-Gassent; Christine L Miller; Mahulena Maruskova; J Seshu
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

2.  The BBA01 protein, a member of paralog family 48 from Borrelia burgdorferi, is potentially interchangeable with the channel-forming protein P13.

Authors:  Marija Pinne; Katrin Denker; Elin Nilsson; Roland Benz; Sven Bergström
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

3.  Borrelia burgdorferi linear plasmid 38 is dispensable for completion of the mouse-tick infectious cycle.

Authors:  Daniel P Dulebohn; Aaron Bestor; Ryan O M Rego; Philip E Stewart; Patricia A Rosa
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

4.  A new animal model for studying Lyme disease spirochetes in a mammalian host-adapted state.

Authors:  D R Akins; K W Bourell; M J Caimano; M V Norgard; J D Radolf
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

5.  Spermine and Spermidine Alter Gene Expression and Antigenic Profile of Borrelia burgdorferi.

Authors:  Ying-Han Lin; Jesus A Romo; Trever C Smith; Ann N Reyes; S L Rajasekhar Karna; Christine L Miller; Tricia A Van Laar; Raghunandan Yendapally; James P Chambers; J Seshu
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

6.  VraA (BBI16) protein of Borrelia burgdorferi is a surface-exposed antigen with a repetitive motif that confers partial protection against experimental Lyme borreliosis.

Authors:  M Labandeira-Rey; E A Baker; J T Skare
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

7.  Overexpression of CsrA (BB0184) alters the morphology and antigen profiles of Borrelia burgdorferi.

Authors:  Eva Sanjuan; Maria D Esteve-Gassent; Mahulena Maruskova; J Seshu
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

8.  Analysis of Borrelia burgdorferi membrane architecture by freeze-fracture electron microscopy.

Authors:  J D Radolf; K W Bourell; D R Akins; J S Brusca; M V Norgard
Journal:  J Bacteriol       Date:  1994-01       Impact factor: 3.490

9.  Contributions of environmental signals and conserved residues to the functions of carbon storage regulator A of Borrelia burgdorferi.

Authors:  S L Rajasekhar Karna; Rajesh G Prabhu; Ying-Han Lin; Christine L Miller; J Seshu
Journal:  Infect Immun       Date:  2013-06-10       Impact factor: 3.441

10.  Effect of levels of acetate on the mevalonate pathway of Borrelia burgdorferi.

Authors:  Tricia A Van Laar; Ying-Han Lin; Christine L Miller; S L Rajasekhar Karna; James P Chambers; J Seshu
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.